These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34583319)

  • 41. Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis.
    Medjo B; Atanaskovic-Markovic M; Radic S; Nikolic D; Lukac M; Djukic S
    Ital J Pediatr; 2014 Dec; 40():104. PubMed ID: 25518734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrolide Resistant Mycoplasma pneumoniae in Community Acquired Pneumonia.
    Varghese SM; Kerkar VV
    Indian J Pediatr; 2020 Nov; 87(11):958. PubMed ID: 32333367
    [No Abstract]   [Full Text] [Related]  

  • 43. Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China.
    Cao B; Ren LL; Zhao F; Gonzalez R; Song SF; Bai L; Yin YD; Zhang YY; Liu YM; Guo P; Zhang JZ; Wang JW; Wang C
    Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1443-8. PubMed ID: 20623362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
    Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
    J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance.
    Lee E; Young Lee Y
    Respir Med; 2020 Dec; 175():106209. PubMed ID: 33186845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative effectiveness of ceftriaxone in combination with a macrolide compared with ceftriaxone alone for pediatric patients hospitalized with community-acquired pneumonia.
    Leyenaar JK; Shieh MS; Lagu T; Pekow PS; Lindenauer PK
    Pediatr Infect Dis J; 2014 Apr; 33(4):387-92. PubMed ID: 24168982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010-2019.
    Lee KL; Lee CM; Yang TL; Yen TY; Chang LY; Chen JM; Lee PI; Huang LM; Lu CY
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):281-291. PubMed ID: 32948415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
    Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
    J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.
    Miyashita N; Kawai Y; Akaike H; Ouchi K; Hayashi T; Kurihara T; Okimoto N;
    BMC Infect Dis; 2012 May; 12():126. PubMed ID: 22650321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China.
    Qu J; Chen S; Bao F; Gu L; Cao B
    Int J Infect Dis; 2019 Jun; 83():26-31. PubMed ID: 30926541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Serologic early diagnosis of pneumonia caused by Mycoplasma pneumoniae].
    Schmidt-Ioanas M; Bender M; Roth A; Allewelt M; de Roux A; Lode H
    Dtsch Med Wochenschr; 2006 Mar; 131(12):613-7. PubMed ID: 16544236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia.
    Cardinale F; Chironna M; Dumke R; Binetti A; Daleno C; Sallustio A; Valzano A; Esposito S
    Eur Respir J; 2011 Jun; 37(6):1522-4. PubMed ID: 21632830
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
    Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
    Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain.
    Rivaya B; Jordana-Lluch E; Fernández-Rivas G; Molinos S; Campos R; Méndez-Hernández M; Matas L
    J Antimicrob Chemother; 2020 Oct; 75(10):2752-2759. PubMed ID: 32653897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA.
    Lanata MM; Wang H; Everhart K; Moore-Clingenpeel M; Ramilo O; Leber A
    Emerg Infect Dis; 2021 Jun; 27(6):1588-1597. PubMed ID: 34013867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia: A retrospective study.
    Lan Y; Li S; Yang D; Zhou J; Wang Y; Wang J; Xu Y; Chen Z
    Medicine (Baltimore); 2020 May; 99(19):e19987. PubMed ID: 32384451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of macrolide therapy in patients hospitalized with Pseudomonas aeruginosa community-acquired pneumonia.
    Laserna E; Sibila O; Fernandez JF; Maselli DJ; Mortensen EM; Anzueto A; Waterer G; Restrepo MI
    Chest; 2014 May; 145(5):1114-1120. PubMed ID: 24458223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Mulholland S; Gavranich JB; Gillies MB; Chang AB
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Gardiner SJ; Gavranich JB; Chang AB
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD004875. PubMed ID: 25566754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
    Ouchi K
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.